# Sphenopalatine Ganglion Block Study

> **NCT05707754** · PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 220 (actual)

## Conditions studied

- Sphenopalatine Ganglion Nerve Block

## Interventions

- **DRUG:** Bupivacaine
- **DEVICE:** angiocatheter

## Key facts

- **NCT ID:** NCT05707754
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-06
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05707754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05707754, "Sphenopalatine Ganglion Block Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05707754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*